For instance, a vectored monoclonal antibody against human epidermal growth factor-2 (HER2) is under development for breast cancer brain metastases21; the off-target activity of the antibody on HER2 expressed in the heart is associated with heart failure.22 This evidence concerns the gene ERBB2 and breast carcinoma.